AMY LIPP: Open Payments
NPI 1942684816 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,574 in 159 payments from 19 companies in 2025. Trend: 2023 $984 · 2024 $2,840 · 2025 $2,574
Food & beverage: $2,475Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $419 |
| Janssen Biotech, Inc. | 25 | $374 |
| UCB, Inc. | 10 | $252 |
| PFIZER INC. | 18 | $239 |
| Galderma Laboratories, L.P. | 20 | $227 |
| GENZYME CORPORATION | 10 | $189 |
| Arcutis Biotherapeutics, Inc. | 18 | $165 |
| Lilly USA, LLC | 7 | $160 |
| Novartis Pharmaceuticals Corporation | 4 | $91 |
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
Products named: TREMFYA, RINVOQ, Bimzelx, CIBINQO, DUPIXENT, NEMLUVIO, Zoryve, SKYRIZI.
Industry payments across OH — which companies pay providers there.
